The ongoing supply chain bottlenecks will likely incrementally ease from here. That said - we still see plenty of uncertainties ahead.
As a results of these developments, markets and policymakers have had to continuously adjust their expectations for inflation as well as policy. This has contributed a lot to the recent interest rate and equity market volatilities.
That said, it is interesting to note that, of late, some parts of the supply side inflation pictures has looked a little better. The BDIY (Baltic Exchange Dry Index) which measures the price of moving major raw materials globally across 23 different routes, have fallen by more than 50% since hitting a post-Global Financial Crisis high in early October. The closely watched shipping rates between China and the West and East coasts of the United States, and pulled back by around 30% since mid-September. After sounding alarms about shortages over the last few weeks, more CEOs and CFOs of large US companies have also sent more reassuring signals lately about having sufficient supplies over the year-end holiday season. In Asia, after the unexpected severe Delta wave hit productions in the summer, manufacturing activity appear to be bouncing back. The pandemic looks better contained and vaccination rate has picked up.
So far these improvements appears to be incremental, as well as uneven. Supplier Delivery Times, as measured by Markit PMI for the US, continue to hover at a historically low level –suggesting unprecedented waiting times. Even in shipping, routes outside of the US and China, for example, shipping rates between China to Europe, have merely plateaued, rather than declined, and remain at a historic high level. Thus it is possible that a confluence of factors, including demand, supply, inventory, as well as the effect of the pandemic are still stressing some parts of the global supply chain. And even while company executives have sounded more optimistic lately, the majority only expect supply chain disruptions to be solved in mid-2022.
Given the considerable uncertainty with regard to how the pandemic will evolve in the coming months, this means it is still premature to say that supply side inflation is going away for good, or even peaked on a global scale. That said, given inflation expectations are already running high, and rates markets have moved pre-emptively with regard to rate hikes, some easing of supply side issues will nonetheless be a positive tailwind for risk assets, as well as allowing us to fade some of the more aggressive interest rate pricings. In an earlier report, we discussed how central banks policies may diverge in 2022, largely based on the differences in their inflation tolerance level. Although some central banks have already reacted more hawkishly, we believe the Fed and the ECB will likely hold on to a more gradual path of policy normalisation. This is a key assumption behind our more positive views on global equities, particularly developed market equities in 2022. Over the last few months, concerns over supply chain issues have increased markedly. After the Delta wave hit Asian production in the summer, many developed economies also experienced more local supply chain issues, from labour shortages, to logistic problems. All of these have fed into a market narrative which was already quite worried about inflation since the beginning of the year. The rally in commodity prices in October, plus a sluggish recovery in labour market participation rate in developed markets, exacerbated these concerns.
As a results of these developments, markets and policymakers have had to continuously adjust their expectations for inflation as well as policy. This has contributed a lot to the recent interest rate and equity market volatilities.
That said, it is interesting to note that, of late, some parts of the supply side inflation pictures has looked a little better. The BDIY (Baltic Exchange Dry Index) which measures the price of moving major raw materials globally across 23 different routes, have fallen by more than 50% since hitting a post-Global Financial Crisis high in early October. The closely watched shipping rates between China and the West and East coasts of the United States, and pulled back by around 30% since mid-September. After sounding alarms about shortages over the last few weeks, more CEOs and CFOs of large US companies have also sent more reassuring signals lately about having sufficient supplies over the year-end holiday season. In Asia, after the unexpected severe Delta wave hit productions in the summer, manufacturing activity appear to be bouncing back. The pandemic looks better contained and vaccination rate has picked up.
So far these improvements appears to be incremental, as well as uneven. Supplier Delivery Times, as measured by Markit PMI for the US, continue to hover at a historically low level –suggesting unprecedented waiting times. Even in shipping, routes outside of the US and China, for example, shipping rates between China to Europe, have merely plateaued, rather than declined, and remain at a historic high level. Thus it is possible that a confluence of factors, including demand, supply, inventory, as well as the effect of the pandemic are still stressing some parts of the global supply chain. And even while company executives have sounded more optimistic lately, the majority only expect supply chain disruptions to be solved in mid-2022.
Given the considerable uncertainty with regard to how the pandemic will evolve in the coming months, this means it is still premature to say that supply side inflation is going away for good, or even peaked on a global scale. That said, given inflation expectations are already running high, and rates markets have moved pre-emptively with regard to rate hikes, some easing of supply side issues will nonetheless be a positive tailwind for risk assets, as well as allowing us to fade some of the more aggressive interest rate pricings. In an earlier report, we discussed how central banks policies may diverge in 2022, largely based on the differences in their inflation tolerance level. Although some central banks have already reacted more hawkishly, we believe the Fed and the ECB will likely hold on to a more gradual path of policy normalisation. This is a key assumption behind our more positive views on global equities, particularly developed market equities in 2022.
Authors:
Alex Wolf, Head of Investment Strategy for Asia
Julia Wang, Global Market Strategist
Yuxuan Tang, Global Market Strategist
Weiheng Chen, Global Market Strategist
For over a year, supply bottlenecks have been impacting businesses across sectors and geographies, pushing up prices and biting into margins. Due to the significant implications on growth and markets, investors are watching closely for any signs of improvement. In today’s note, we examine the current situation, potential early signs of easing, as well as the uncertainties looking ahead.
Disruptions from production shutdowns and mobility restrictions have pressured global supply chains since the early stage of the pandemic, but the initial shock quickly faded as major manufacturing hubs (i.e. China, ASEAN) quickly went back online. That’s why supply shortages were not on most investors’ radars until late 2020, when shipping costs skyrocketed and delivery lags increased in the U.S. and Europe, as consumer demand in the developed world staged a strong recovery on the back of reopening and large stimulus. Since then, the situation has continued to deteriorate due to a combination of factors (see more in our previous report).
Having dealt with the situation for a year now, it’s a good time to review where we stand. The below chart maps out survey results across the globe on the average length of time agreed by suppliers to deliver their goods. A number above 50 means faster delivery compared with a month ago, and vice versa. Broadly, we have not yet seen clear signs of improvement. By geography, the developed world is much more severely impacted due to a higher reliance on imports of consumer goods. In Asia, Japan is experiencing a significant impact due to its position as largely an end-consumer on supply chains, similar to its western developed peers. Taiwan stands to fare the worst, largely due to semiconductor-specific factors (but it also seems to have passed the trough). Most emerging economies in Asia are less impacted thanks to their domestic production capabilities.
The general situation of supply shortages is likely to persist for a while. However, tentative bright spots have started to emerge in certain areas. Recent data shows both production and shipping constraints in key manufacturing economies appear to be past the worst.
First, the worst of the COVID wave – and by extension factory shutdowns and labor shortages – appears to have passed in critical manufacturing economies in Southeast Asia, including Vietnam and Malaysia. Production appears to be gradually recovering there, which provides some much-needed relief for embattled retailers and manufacturers in developed markets struggling with shortages of consumer goods and key industrial components exported from the region.
In addition, port congestions, especially on the U.S. West Coast, have been another flashpoint for supply shortages. High numbers of container ships are still idling offshore waiting to unload their cargo, though there are early indications that the situation is also improving, with the number of idle containers down 30% since a fine was instituted.1
Given market concerns about the impact of rising shipping costs on corporate margins, it is informative to hear how corporations are managing the situation, and understand their views and plans for the coming months. For example, Walmart chartered its own ships to get around shipping congestion and maintains a comfortable level of inventory heading into the holiday season. They also expressed confidence in sales growth to offset supply issues.2 Autos, the epicenter of supply shortages (especially in semiconductors), have also started hinting at an improving situation. Toyota announced that it will begin making up for lost production in December, with their Japanese factories returning to normal capacity for the first time in seven months. GM noted that semiconductor supply has improved and that it had no idle North American assembly plants for the first time since February.3 While these are just anecdotes, they could suggest a turning point in confidence for corporations navigating this saga.
A recent CFO survey by the Richmond and Atlanta Fed also suggests optimism – 60-70% of U.S. companies expect production and shipping delays to resolve over the course of next year, and they are also taking steps to diversify supply chains and increase inventories to manage these issues. This bodes well for the potential beneficiaries from increased capex and manufacturing demand.
In our view, the ongoing supply chain bottlenecks will likely incrementally ease from here, driven by further reopening, mitigation efforts by corporates, as well as waning pent-up demand. That said, there are still plenty of uncertainties ahead. First and foremost, it will be critical to watch the continued evolution of the pandemic in the coming months. Should there be another wave of infections caused by winter weather, or if new mutations lead to renewed lockdowns in production hubs – the situation could get worse before it gets better. We are also watching out for some key time periods, i.e. the upcoming Christmas season and the 2022 Lunar New Year. There were some warnings of acute goods shortages going into the holidays, though major retailers in the U.S. appear confident that they are able to keep shelves stocked. The Lunar New Year in February 2022 will likely shut factories in China and slow output, potentially giving some breathing room for shipping backlogs to clear. Another potential flashpoint on the horizon may occur in Spring 2022 when West Coast dockworkers are set to renegotiate their labor contracts, which are due to expire in July. Complications or tensions in those negotiations could lead to potential strikes (which have happened before) and in turn worsen port congestion.
What does it all mean for investors?
Given the considerable amount of uncertainty, it is still premature to say that supply-side inflation is going away for good, or has even peaked on a global scale. That said, given inflation expectations are already running high, and rates markets have moved pre-emptively with regard to rate hikes, some easing of supply bottlenecks may nonetheless be a positive tailwind for risk assets, and allow us to fade some of the more aggressive interest rate pricings.
Therefore, we maintain our constructive views on global equities, particularly in developed markets. As we discussed in an earlier report, central bank policies may diverge in 2022, largely based on the differences in their inflation tolerance levels. However, although some central banks have reacted in a more hawkish way, we believe the Fed and the ECB will likely be able to hold on to a more gradual path of policy normalization, which is the anchor of our views.
1 Blomberg Finance L.P., as of November 17, 2021. https://www.bloomberg.com/news/articles/2021-11-16/container-glut-eases-as-los-angeles-port-threatens-penalties?sref=L75TRUmI
2 The New York Times, as of November 16, 2021. https://www.nytimes.com/2021/11/16/business/walmart-3q-2021-earnings.html
3 Reuters, FactSet, as of November 12, 2021. https://www.reuters.com/business/autos-transportation/toyota-says-it-will-start-making-up-lost-production-december-2021-11-12/
The Purchasing Managers' Index (PMI) is an index of the prevailing direction of economic trends in the manufacturing and service sectors. It consists of a diffusion index that summarizes whether market conditions, as viewed by purchasing managers, are expanding, staying the same, or contracting. The purpose of the PMI is to provide information about current and future business conditions to company decision makers, analysts, and investors.
All market and economic data as of November 18, 2021 and sourced from Bloomberg Finance L.P. and FactSet unless otherwise stated.
For illustrative purposes only. Estimates, forecasts and comparisons are as of the dates stated in the material.
There can be no assurance that any or all of these professionals will remain with the firm or that past performance or success of any such professional serves as an indicator of the portfolio’s success.
We believe the information contained in this material to be reliable but do not warrant its accuracy or completeness. Opinions, estimates, and investment strategies and views expressed in this document constitute our judgment based on current market conditions and are subject to change without notice.
Although third-party information has been obtained from sources believed to be reliable, JPMorgan Chase & Co. and its affiliates do not guarantee its accuracy or completeness and accept no liability for any direct or consequential losses arising from its use.
By visiting a third-party site, you may be entering an unsecured website. J.P. Morgan is not responsible for, and does not control, endorse or guarantee, any aspect of any linked third-party site. J.P. Morgan accepts no direct or consequential losses arising from the use of such sites.
Structured products involve derivatives. Do not invest in these products unless you fully understand and are willing to assume the associated risks. The most common risks include, but are not limited to, risk of adverse or unanticipated market developments, issuer credit quality risk, risk of lack of uniform standard pricing, risk of adverse events involving any underlying reference obligations, risk of high volatility, risk of illiquidity/little to no secondary market, and conflicts of interest. Before investing in a structured product, investors should review the accompanying offering document, prospectus or prospectus supplement to understand the actual terms and key risks associated with each individual structured product. Any payments on a structured product are subject to the credit risk of the issuer and/or guarantor. Investors may lose their entire investment, i.e., incur an unlimited loss. The risks listed above are not complete. For a more comprehensive list of the risks involved with this particular product, please speak to your J.P. Morgan team. If you are in any doubt about the risks involved in the product, you may clarify with the intermediary or seek independent professional advice.
In discussion of options and other strategies, results and risks are based solely on hypothetical examples cited; actual results and risks will vary depending on specific circumstances. Investors are urged to consider carefully whether option or option-related products in general, as well as the products or strategies discussed herein are suitable to their needs. In actual transactions, the client’s counterparty for OTC derivatives applications is JPMorgan Chase Bank, N.A. and its affiliates. For a copy of the “Characteristics and Risks of Standardized Options” booklet, please contact your J.P. Morgan team.
This document may also have been made available in a different language, at the recipient’s request, and for convenience only. Notwithstanding the provision of a convenience copy, the recipient re-confirms that he/she/they are fully conversant and has full comprehension of the English language. In the event of any inconsistency between such English language original and the translation, including without limitation in relation to the construction, meaning or interpretation thereof, the English language original shall prevail.
Indices are not investment products and may not be considered for investment.
We are not recommending the use of benchmarks as a tool for performance analysis purposes. The benchmarks used in this report are for your reference only.
Some of the products and/or services mentioned may not be available in all jurisdictions.
RISK CONSIDERATIONS
• Past performance is not indicative of future results. You may not invest directly in an index.
• The prices and rates of return are indicative as they may vary over time based on market conditions.
• Additional risk considerations exist for all strategies.
• The information provided herein is not intended as a recommendation of or an offer or solicitation to purchase or sell any investment product or service.
• Opinions expressed herein may differ from the opinions expressed by other areas of J.P. Morgan. This material should not be regarded as investment research or a J.P. Morgan investment research report.